Sponsored by
Latest
Topics
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Featured
M&A
Data Integration Drives Successful Mergers
In an M&A transaction, disparate data and disconnected systems require a data integration game plan.
By
Stacy Galligan
| May 16, 2022
Read More
Resources
CFO Live
Sign Up
Menu
Topics
Accounting & Tax
Corporate Finance
Human Capital
Risk & Compliance
Strategy
Technology
Explore
Search
Latest
Resources
CFO Live
Sign Up
Sponsored by
Revlimid
M&A
Bristol-Myers to Buy Big Pharma Rival Celgene
The $74 billion deal could create the fourth-largest U.S. pharma firm, with a portfolio that includes nine blockbuster drugs.
By
Matthew Heller
| January 3, 2019
Read More
